AU2018900788A0 - Liquid crystalline dosage form for administering a statin - Google Patents
Liquid crystalline dosage form for administering a statinInfo
- Publication number
- AU2018900788A0 AU2018900788A0 AU2018900788A AU2018900788A AU2018900788A0 AU 2018900788 A0 AU2018900788 A0 AU 2018900788A0 AU 2018900788 A AU2018900788 A AU 2018900788A AU 2018900788 A AU2018900788 A AU 2018900788A AU 2018900788 A0 AU2018900788 A0 AU 2018900788A0
- Authority
- AU
- Australia
- Prior art keywords
- statin
- administering
- dosage form
- liquid crystalline
- crystalline dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002552 dosage form Substances 0.000 title 1
- 239000007788 liquid Substances 0.000 title 1
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18787675.0A EP3612166A4 (en) | 2017-04-20 | 2018-04-20 | Liquid crystalline dosage form for administering a statin |
| PCT/AU2018/050367 WO2018191794A1 (en) | 2017-04-20 | 2018-04-20 | Liquid crystalline dosage form for administering a statin |
| AU2018255510A AU2018255510B2 (en) | 2017-04-20 | 2018-04-20 | Liquid crystalline dosage form for administering a statin |
| US16/606,149 US11638698B2 (en) | 2017-04-20 | 2018-04-20 | Liquid crystalline dosage form for administering a statin |
| US18/054,055 US20230277463A1 (en) | 2017-04-20 | 2022-11-09 | Liquid crystalline dosage form for administering a statin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2018900788A0 true AU2018900788A0 (en) | 2018-03-29 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276232A (en) | Pharmaceutical compounds | |
| GB201911928D0 (en) | Pharmaceutical compounds | |
| GB201810245D0 (en) | Pharmaceutical compounds | |
| EP3784214A4 (en) | Liquid oral pharmaceutical dosage form | |
| EP3965733A4 (en) | Abuse-deterrent dosage forms containing esketamine | |
| GB201911944D0 (en) | Pharmaceutical compounds | |
| GB201810239D0 (en) | Pharmaceutical compounds | |
| GB201914910D0 (en) | Pharmaceutical compounds | |
| IL289619A (en) | Pharmaceutical composition comprising a tetrahydropyrazolopyrimidinone compound | |
| EP4045111A4 (en) | Device for delivering medication to a patient | |
| GB201819961D0 (en) | Pharmaceutical compounds | |
| IL291570A (en) | Pharmaceutical compounds | |
| GB202103724D0 (en) | Pharmaceuticals solution for oral dosage | |
| EP3815688A4 (en) | Pharmaceutical composition containing poorly-soluble basic medicine | |
| GB201819960D0 (en) | Pharmaceutical compounds | |
| EP3612166A4 (en) | Liquid crystalline dosage form for administering a statin | |
| GB201801562D0 (en) | Pharmaceutical compounds | |
| GB201800378D0 (en) | Pharmaceutical compounds | |
| GB202010409D0 (en) | Pharmaceutical compounds | |
| EP4005614A4 (en) | Drug solution injection device | |
| EP3856177A4 (en) | Grapiprant unit dosage forms | |
| GB201816369D0 (en) | Pharmaceutical compounds | |
| AU2018900788A0 (en) | Liquid crystalline dosage form for administering a statin | |
| AU2017905102A0 (en) | Liquid crystalline dosage form for administering a statin | |
| GB201915932D0 (en) | Pharmaceutical compounds |